+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Global Biomarkers Market, By Product , Type, Disease Indication, Application, By Region; Trend Analysis, Competitive Market Share & Forecast, 2016-2026

  • ID: 5135074
  • Report
  • June 2020
  • Region: Global
  • 165 pages
  • Blueweave Consulting & Research Pvt Ltd


  • Abbott Laboratories
  • Bio-Rad Laboratories
  • EKF Diagnostics
  • Enzo Biochem Inc.
  • F. Hoffmann-La Roche Ltd
  • Merck KGaA
Biomarkers are widely used in the analysis and management of multiple diseases. Physiological levels of biomarkers also change upon the administration of drugs. The study of numerous biomarkers helps clinicians make meaningful choices about the analysis, disease stage, therapy plan, and prognosis in patients.

The high occurrence of cancer is inspiring research initiatives, motivating the development of the market. Extensive research and technological advancements used for the development of biomarker-based clinical diagnostics are predictable to be the key funders for exchange. An increase in the global affliction of long-lasting diseases, particularly cardiovascular, cancer, diabetes disorders due to an inactive lifestyle, unhealthy diet, and lack of exercise, has been a significant factor motivating the market growth. Increasing R&D fueling for pharma and biotech companies, a growing number of CROs and low cost of clinical trials in emerging countries, the high occurrence of cancer, and new edges for research. On the other hand, high capital savings and low cost-benefit ratio poorly suited regulatory and repayment systems, and technical issues related to sample group and storage are the significant reasons confining the growth of this market.

The request for diagnostic markets is growing. Where unoriginal diagnostic tools were focused on making accurate and reliable results, today’s market request extends to new analysis with actual and steady results. There are essential challenges in presenting accurate results in the early stage of diseases, especially in the case of cancer.

Investigative biomarkers are negligible or non-invasive tools. Biomarkers, combined with crucial imaging and data management technologies, are meeting the market prospects; however, they have setbacks too. Biomarkers are used in imaging technology to deliver precise imaging of oncology tumors and other problems and remove the chance of energy revelation during imaging through CT scan and MRI scan.

Growth Drivers

Increasing usage of biomarkers in cancer treatment is driving the market growth.

Biomarkers are used in application areas such as companion diagnostics, personalized medicines, and other diagnostic areas, including drug discovery and growth and disease risk assessment. These growing diagnostic uses of biomarkers are predictable to drive market growth in the coming years. Companion diagnostics and biomarkers have become progressively pertinent in the practice of medicine, foremost to improved diagnosis, dealing, and monitoring across several disease areas. It can be used to recognize patients likely to reply well to certain drugs or cure options. These diagnostics are often used in combination with a specific drug.

Technological Advancement

Technological advancements have permitted the grouping of biomarkers with novel drugs for precise diagnosis and following cure options. For instance, biomarkers can be functional for the cure of several neurological diseases by stalking brain health and activity by examining biomolecules. Nascent developments, such as biomarker signatures, have augmented the treatment rate of nervous disorders resulting in early diagnosis, non-invasive testing, and rapid drug development.

This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown


  • Abbott Laboratories
  • Bio-Rad Laboratories
  • EKF Diagnostics
  • Enzo Biochem Inc.
  • F. Hoffmann-La Roche Ltd
  • Merck KGaA

1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation

2. Research Methodology
2.1. Qualitative Research
2.1.1. Primary & Secondary Sources
2.2. Quantitative Research
2.2.1. Primary & Secondary Sources
2.3. Market Breakdown & Data Triangulation
2.3.1. Secondary Research
2.3.2. Primary Research
2.4. Breakdown of Primary research respondent, By Region
2.5. Assumption & Limitation

3. Executive Summary

4. Global Biomarker market Industry Insights
4.1. Industry Value Chain Analysis
4.2. DROC Analysis
4.2.1. Growth Drivers
4.2.2. Restraint
4.2.3. Opportunities
4.2.4. Challenges
4.3. Technological Landscape/Recent Development
4.4. Regulatory Framework
4.5. Company Market Share Analysis, 2019
4.6. Porter’s Five Forces Analysis
4.6.1. Bargaining Power of Suppliers
4.6.2. Bargaining Power of Buyers
4.6.3. Threat of New Entrants
4.6.4. Threat of Substitutes
4.6.5. Intensity of Rivalry
4.7. Impact of COVID 19

5. Global Biomarker market Overview
5.1. Market Size & Forecast by Value, 2016-2026
5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1. By Product Consumables Service
5.2.2. By Type Safety Efficacy Validation
5.2.3. By Disease Indication Cancer Cardiovascular Disorders
5.2.4. By Application Diagnostics Development Drug Discovery and Development Disease-Risk
5.2.5. By Region North America Europe Asia Pacific Latin America Middle East & Africa

6. North America Biomarker Market
6.1. Market Size & Forecast by Value, 2016-2026
6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Type
6.2.3. By Disease Indication
6.2.4. By Application
6.2.5. By Country United States Canada

7. Europe Biomarker market
7.1. Market Size & Forecast by Value, 2016-2026
7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Type
7.2.3. By Disease Indication
7.2.4. By Application
7.2.5. By Country Germany United Kingdom France Italy Spain Rest of Europe

8. Asia Pacific Biomarker Market
8.1. Market Size & Forecast by Value, 2016-2026
8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Type
8.2.3. By Disease Indication
8.2.4. By Application
8.2.5. By Country India China Japan South Korea Rest of Asia Pacific

9. Latin America Biomarker Market
9.1. Market Size & Forecast by Value, 2016-2026
9.1.1. By Value (USD Million)
9.2. Market Share & Forecast By Product By Type By Disease Indication By Application By Country Brazil Mexico Rest of Latin America

10. Middle East & Africa Biomarker Market
10.1. Market Size & Forecast by Value, 2016-2026
10.1.1. By Value (USD Million)
10.2. Market Share & Forecast By Product By Type By Disease Indication By Application By Country Saudi Arabia UAE South Africa Rest of Middle East & Africa

11. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook)*
11.1. Qiagen N.V.
11.2. Thermo Fisher Scientific Inc.
11.3. F. Hoffmann-La Roche Ltd
11.4. PerkinElmer Inc.
11.5. Merck KGaA
11.6. Bio-Rad Laboratories
11.7. Abbott Laboratories
11.8. EKF Diagnostics
11.9. Enzo Biochem Inc.
11.10. Meso Scale Diagnostics, LLC
11.11. Signosis
11.12. Other Prominent Players
* Financial details in case of unlisted companies will be available as per data availability
**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable.

Note: Product cover images may vary from those shown


  • Qiagen N.V.
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd
  • PerkinElmer Inc.
  • Merck KGaA
  • Bio-Rad Laboratories
  • Abbott Laboratories
  • EKF Diagnostics
  • Enzo Biochem Inc.
  • Meso Scale Diagnostics LLC
  • Signosis
  • PerkinElmer Inc
Note: Product cover images may vary from those shown